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Fig. 1. The matching result of 2-D gel map of proteins from PBMC of HCV
infected patients and healthy persons.
Fig. 2. Detecting F protein and PI3K by Western blot analysis. M: Protein
marker; 1, 4, 5: pcDNA3.0-HepG2; 2, 3, 6: pcDNA3.0-F-HepG2.
signiﬁcant inﬂuence on cell signal pathway. HCV-F protein can
activate PI3K protein and its signal cascade pathway. Therefore,
HCV-F protein may plays an important role in HCV pathogenesis.
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Objective: To explore the feasibility of induction of neutraliza-
tion antibodies against HCV infection by DNA vaccines.
Methods: Two expression plasmids of HCV envelope 2 protein
were constructed, plasmid pCI-1b746 encoding full length of E2
protein, and plasmid pCI-1b661 encoding hydrophobic carboxyl
terminal truncated E2. 293T cells were transfected with either
of both plasmids, respectively, and intracellular and secreted E2
protein were analyzed by Western blot or immunoﬂuorescence.
Then the plasmids were used to immunize BALB/c mouse in-
tramusclarly. The sera antibodies against E2 and hypervariable
region 1 (HVR1) were detected by ELISA and the neutralization
activity of the sera were assayed with HCV pseudotype particle
(HCVpp).
Results: Both plasmids could express HCV E2 protein, the ex-
pression product of pCI-1b746 could not secrete, while that of
pCI-1b661 could secrete into culture medium. The secretion of
HCV E2 protein enhanced antibody response elicited by DNA vac-
cines in mice signiﬁcantly. Sera from pCI-1b661 immunized mice
showed stronger neutralization activity than that from pCI-1b746
immunized mice. For sera from pCI-1b661 immunized mice, the
neutralization activity against HCVpp were positive correlation
with anti-HVR1 antibodies levels.
Conclusions: Secretion of E2 protein by DNA vaccine can enhance
the production of neutralization antibodies against HCVpp infec-
tion and the neutralizing activity is depended on the presence of
HVR1 antibodies.
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Aim: To evaluated relationship of the changes of transforming
growth factor-β1 (TGF-β), matrix metalloproteinase-1 (MMP-1)
and tissue inhibitors of matrix metalloproteinase-1 (TIMP-1) ex-
pression with liver ﬁbrosis in liver tissue after IFN-α therapy in
patients with chronic hepatitis C.
Methods: Eleven patients with chronic hepatitis C treated by
IFN-α were divided into two groups on the outcome of therapy,
including a complete responder group (CR) and a non-responder
group (NR). Liver biopsy specimens were stained with hema-
toxylin and eosin (HE) and Masson’s trichrome staining. Liver
ﬁbrosis was semiquantitated by Modiﬁed Ishak scoring system.
Results: There was a signiﬁcant reduction in Ishak ﬁbrosis score
in SVR group (P<0.05). The TGF-β1 expression was reduced and
the MMP-1 expression was elevated in SVR groups after IFN-α
therapy (P<0.05). The ratio of the density of MMP-1 to TIMP-1
expression increased in SVR group after IFN-α therapy compared
with NR group (P<0.05). The reduction of ﬁbrosis score corre-
lated signiﬁcantly with that of TGF-β1 expression in all patients
(R=0.744, P<0.01). The increase of MMP-1 expression after IFN-α
therapy signiﬁcantly correlated with the decrease of ﬁbrosis
(R=-0.925, P<0.05) and HAI (R=-0.837, P<0.05) scores in SVR
group.
Conclusion: IFN-α improves liver ﬁbrosis in hepatitis C patients
by decreasing TGF-β1 expression, as well as by increasing MMP-1
expression to degrade ﬁbrosis.
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Background: Hepatic oval cells differentiate into two types of
cells, hepatocytes and biliary cells. The aim of this study was to
identify oval cells in fetal liver and in adult liver from patients
with chronic C hepatitis.
Method: This study was performed using two study group. The
ﬁrst included 10 human fetal livers from embryos from ther-
apeutical abortions with gestational ages ranging betwwen 10
and 21 weeks. The second group included 30 liver biopsies from
patients with viral C hepatitis. The liver specimens were ﬁxed
in formaldehyde, embedded in parafﬁn and cut at 5 μm. Slides
were stained using standard (HE, VG) and immunohistochemical
stainings (CK19, CD45, alfaSMA and desmin).
Results: All cases were examined by light microscopy. Oval cells
were identiﬁed as small cells with basophilic cytoplasm and
small oval nuclei, located in periportal areas, and in association
with ﬁbrosis and inﬂammation. They were positive for CK19 and
negative for CD45. Desmin was positive in fetal hepatocytes and
negative in adult hepatocytes. Alfa SMA was positive in periportal
cells and negative in hepatocytes and biliar ducts. In chronic C
hepatitis alfa SMA was positive in isolated cells in the areas of
necrosis.
